Compare EVO & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | RMNI |
|---|---|---|
| Founded | 1993 | 2005 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 568.6M | 457.2M |
| IPO Year | 2007 | 2015 |
| Metric | EVO | RMNI |
|---|---|---|
| Price | $1.62 | $4.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $7.00 | $5.00 |
| AVG Volume (30 Days) | 143.7K | ★ 334.4K |
| Earning Date | 04-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 197.50 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $431,496,000.00 |
| Revenue This Year | $1.37 | $6.02 |
| Revenue Next Year | $10.05 | $5.50 |
| P/E Ratio | ★ N/A | $103.63 |
| Revenue Growth | N/A | ★ 5.33 |
| 52 Week Low | $1.50 | $2.87 |
| 52 Week High | $4.27 | $5.68 |
| Indicator | EVO | RMNI |
|---|---|---|
| Relative Strength Index (RSI) | 38.78 | 29.46 |
| Support Level | $1.50 | $4.01 |
| Resistance Level | $1.97 | $4.34 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 42.59 | 4.24 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. The company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management, database, and technology software systems. Geographically, the company generates its revenue from the United States of America and the International market.